Business
BELLUS Health Announces Pricing of up to $20M Equity Offering
BELLUS Health Announces Pricing of up to $20M Equity Offering Canada NewsWire LA...
About this update from Bluenergies Ltd.
[{"type":"text","content":"\n\n\n\nBELLUS Health Announces Pricing of up to $20M Equity Offering\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n\n\n\n\n\n\n\nCanada NewsWire\nLAVAL, QC, Dec. 5, 2017\n\n\n\n/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/\n\n\n\nLAVAL, QC, Dec. 5, 2017 /CNW/ - BELLUS Health Inc. (TSX: BLU) (BELLUS Health or the Company) today announced that it has priced its overnight marketed equity offering announced yesterday and its lead agent, Bloom Burton Securities Inc., on behalf of a syndicate of agents that includes Cormark Securities Inc. and Mackie Research Capital Corporation, has confirmed up to $20 million in demand for common shares at a price of $0.38 per share. The offering is to be effected on a best efforts basis in each of the Canadian provinces by way of a prospectus supplement to BELLUS Health's base shelf prospectus dated November 23, 2017. In addition, the common shares may also be offered for sale in the United States through one or more United States registered broker-dealer(s) appointed by the agents as sub-agent(s) pursuant to exemptions from the registration requirements of the United States Securities Act of 1933, as amended (the \"U.S. Securities Act\") and applicable state laws. Prior to the completion of the offering, BELLUS Health has 66,866,001 common shares issued and outstanding.\n\nIn connection with the offering, the agents will be paid a cash commission equal to 6.0% of the gross proceeds of up to $10,000,000 raised in connection with the offering, 5.0% of the gross proceeds (if any) in excess of $10,000,000 raised in connection with the offering (in each case excluding any common shares sold to certain excluded subscribers in respect of which the cash commission will be reduced to 3.0%). In addition, the agents will be issued that number of non-transferable broker warrants exercisable for common shares equal to (i) 4.0% of the number of common shares issued under the portion of the offering representing gross proceeds of up to $10,000,000 (excluding any ...